ArticleEquine veterinary journal2026
Development of a health-related quality-of-life assessment tool for equines with pituitary pars intermedia dysfunction.
Article in Equine veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a health-related quality-of-life assessment tool for equines with pituitary pars intermedia dysfunction.Equine veterinary journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundClinical signs of pituitary pars intermedia dysfunction (PPID) are frequently mistaken for 'normal' ageing and may not be optimally assessed. Objective quality of life (QoL) assessment could improve clinical decision-making.
objectivesTo develop an owner-reported health-related quality-of-life (HRQoL) assessment tool for equines with PPID. To assess factors associated with HRQoL scores. STUDY
designQuantitative, cross-sectional study.
methodsHRQoL tool development followed a standard psychometric process of item (any aspect of PPID and its management that could impact QoL) identification (following interviews with veterinarians, owners and clinical record reviews), selection (online owner questionnaire) and refinement (statistical analyses; chi-squared and Cronbach's alpha). General Linear Models were used to identify factors associated with HRQoL scores.
resultsForty-two items associated with PPID were identified. Thirty-seven items were selected for the online questionnaire. In total, 612 complete responses (n = 343 PPID and n = 269 non-PPID horses) were obtained. Through stepwise statistical item refinement, 24 items remained in the final HRQoL tool (overall Cronbach's α = 0.835). HRQoL scores ranged from 0 (best) to 1 (worst) QoL. Median (interquartile range) HRQoL scores were 0.33 (0.22-0.44) and 0.20 (0.14-0.27) for PPID and non-PPID horses respectively. HRQoL scores for all horses were worse if they had PPID (p < 0.001) or other chronic medical conditions and were older (p < 0.015). For PPID horses specifically, HRQoL scores were also worse if they had other chronic medical conditions (p = 0.02), but HRQoL scores were not associated with current PPID treatment (treated vs. untreated horses with a PPID diagnosis), bodyweight, age, breed, sex or years since diagnosis. MAIN LIMITATIONS: Limited numbers of untreated PPID horses.
conclusionThe HRQoL tool is valid and reliable for use in horses with PPID and can be applied in further research. PPID horses with another chronic disease had worse HRQoL scores, which should be considered in other studies evaluating disease impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.